Compressed matrix dual-component vaginal drug delivery system containing metoclopramide hydrochloride
By: Geeta Patel and Madhabhai Patel
Open Access
|Oct 2009References
- K. Vermani and S. Garg, The scope and potential of vaginal drug delivery,, 3 (2000) 359-364; DOI: S1461-5347(00)00296-0.
- P. Colombo, U. Conte and A. Gazzaniga, Drug release modulation by physical restrictions of matrix swelling,. 63 (1990) 43-48; DOI: 10.1016/0378-5173(90)90099-P.
- Y. Qiu, N. Chidambaram and K. Flood, Design and evaluation of layered diffusional matrices for zero-order sustained release,. 51 (1998) 123-130; DOI: PII S0168-3659(97)00119-3.
- N. Chidambaram, W. Porter, K. Flood and Y. Qui, Formulation and characterization of new layered diffusional matrices for zero-order sustained release,. 52 (1998) 149-158; DOI: 10.1016/S0168-3659(97)00207-1.
- U. Conte and L. Maggi, A flexible technology for the linear, pulsative and delayed release drugs, allowing for easy accommodation of difficult in vitro targets,. 64 (2000) 263-268; DOI: 10.1016/S0168-3659(99)00147-9.
- N. M. Zakia, G. A. Awada, N. D. Mortadaa, S. Seham and A. E. Hady, Enhanced bioavailability of metoclopramide HCl by intranasal administration of a mucoadhesivegel with modulated rheological and mucociliary transport properties,. 3 (2007) 296-307; DOI: 10.1016/j.ejps.2007.08.006.
- S. Lybak, E. Kjellen, P. Nilsson, A. Tomaszewicz, J. Wennerberg and R. W. Pero, Normal tissue reactions in mice after combined treatment with metoclopramide and ionizing radiation,. 31 (1992) 469-474.
- J. Wennerberg, E. Kjellen, S. Lybak, R. Rydell and R. Pero, Biochemical modulation of chemotherapy and radiotherapy in head and neck cancer,. 13 (1993) 2501-2506.
- A. Olsson, Y. Sheng, E. Kjellen and R. W. Pero, In vivo tumor measurement of DNA damage, DNA repair and NAD pools as indicators of radiosensitization by metoclopramide,16 (1995) 1029-1035.
- R. A. Harrington, C. W. Hamilton, R. N. Brogden, J. A. Linkewich, J. A. Romankiewicz and R. C. Heel, Metoclopramide: an updated review of its pharmacological properties and clinical use,25 (1983) 451-494.
- D. M. Brahmankar and S. B. Jaiswal,, 1ed., Vallaph Prakashan, Delhi 1998, p. 311.
- H. C. Ansel, L. V. Allen and N. G. Popovich,, in, 7th ed., Lippincott Williams & Wilkins, Philadelphia 2002, pp. 204-209.
- C. N. Patra, A. B. Kumar, H. K. Pandit, S. P. Singh and M. V. Devi, Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride,. 57 (2007) 479-489; DOI: 10.2478/v10007-007-0038-0
- , Asian Edition, USP Convention, Rockville (MD) 2005, p. 1277.
- , U. S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) September 1997, CMC 8, Rockville (MD) 1997, p. 32.
- P. Costa, J. Manuel and S. Labao, Modeling and comparison of dissolution profiles,. 13 (2001) 123-133; DOI: 10.1016/S0928-0987(01)00095-1.
- R. W. Korsmeyer, R. Gurny, E. Docler, P. Buri and N. A. Peppas, Mechanism of solute release from porous hydrophilic polymers,. 15 (1983) 25-35; DOI: 10.1016/0378-5173(83)90064-9.
- N. A. Peppas, Analysis of Fickian and non Fickian drug release from polymers,. 60 (1985) 110-111.
- N. Adel, N. Fatma, A. Ismail, N. A. Boraie and L. M. Mortada, Mucoadhesive delivery systems. I. Evaluation of mucoadhesive polymers for buccal tablet formulation,. 30 (2004) 985-993; DOI: 10.1081/DDC-200037245.
- J. Moore and H. Flanner, Mathematical comparison of dissolution profiles,. 20 (1996) 64-74.
Language: English, Croatian
Page range: 273 - 288
Published on: Oct 9, 2009
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Keywords:
Related subjects:
© 2009 Geeta Patel, Madhabhai Patel, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.